These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 22588654

  • 1. [A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].
    Meyer I, Frank D, Janssens U.
    Dtsch Med Wochenschr; 2012 May; 137(21):1096-9. PubMed ID: 22588654
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman.
    Ranieri P, Franzoni S, Rozzini R, Trabucchi M.
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):75-8. PubMed ID: 9188023
    [Abstract] [Full Text] [Related]

  • 3. [Syndrome of inappropriate antidiuretic hormone secretion in the course of treatment with venlafaxine--case report].
    Chojnacka M, Swiecicki Ł.
    Psychiatr Pol; 2011 Apr; 45(6):933-9. PubMed ID: 22335135
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Burke D, Fanker S.
    Aust N Z J Psychiatry; 1996 Apr; 30(2):295-8. PubMed ID: 8811276
    [Abstract] [Full Text] [Related]

  • 5. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
    Humayun MA, Cranston IC.
    BMC Endocr Disord; 2017 Nov 06; 17(1):69. PubMed ID: 29110656
    [Abstract] [Full Text] [Related]

  • 6. Venlafaxine hyponatraemia: incidence, mechanism and management.
    Roxanas M, Hibbert E, Field M.
    Aust N Z J Psychiatry; 2007 May 06; 41(5):411-8. PubMed ID: 17464733
    [Abstract] [Full Text] [Related]

  • 7. Hyponatremia with venlafaxine.
    Masood GR, Karki SD, Patterson WR.
    Ann Pharmacother; 1998 Jan 06; 32(1):49-51. PubMed ID: 9475820
    [Abstract] [Full Text] [Related]

  • 8. Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.
    Romero S, Pintor L, Serra M, Plana T, Navarro V, Gastó C, Goldstein B.
    Gen Hosp Psychiatry; 2007 Jan 06; 29(1):81-4. PubMed ID: 17189754
    [Abstract] [Full Text] [Related]

  • 9. Syndrome of inappropriate secretion of antidiuretic hormone due to desvenlafaxine.
    Lee Gt, Leung Jl.
    Gen Hosp Psychiatry; 2013 Jan 06; 35(5):574.e1-3. PubMed ID: 22818163
    [Abstract] [Full Text] [Related]

  • 10. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ, Ahmad F, Blais JD, Chiodo J, Zhou W, Glaser LA, Czerwiec FS.
    Cancer Med; 2017 Apr 06; 6(4):723-729. PubMed ID: 28251822
    [Abstract] [Full Text] [Related]

  • 11. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
    Mali P, Muduganti SR, Mujibur R, Murali N.
    WMJ; 2015 Apr 06; 114(2):66-8. PubMed ID: 26756059
    [Abstract] [Full Text] [Related]

  • 12. [SIADH with epileptic seizures and coma in fluoxetine therapy].
    Romerio SC, Radanowicz V, Schlienger RG.
    Praxis (Bern 1994); 2000 Mar 02; 89(10):404-10. PubMed ID: 10731855
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
    Chen S, Zhao JJ, Tong NW, Guo XH, Qiu MC, Yang GY, Liu ZM, Ma JH, Zhang ZW, Gu F.
    J Clin Pharmacol; 2014 Dec 02; 54(12):1362-7. PubMed ID: 24906029
    [Abstract] [Full Text] [Related]

  • 14. Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
    Han SW, Yi JH, Kang KP, Kim HY, Kim SW, Choi HY, Ha SK, Kim GH, Kim YW, Jeong KH, Shin SK, Kim HJ.
    J Korean Med Sci; 2018 Apr 09; 33(15):e112. PubMed ID: 29629516
    [Abstract] [Full Text] [Related]

  • 15. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A, McCormick L, Rahman M.
    Adv Ther; 2021 Dec 09; 38(12):5721-5736. PubMed ID: 34693505
    [Abstract] [Full Text] [Related]

  • 16. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
    Harbeck B, Lindner U, Haas CS.
    Endocrine; 2016 Sep 09; 53(3):872-3. PubMed ID: 26961548
    [No Abstract] [Full Text] [Related]

  • 17. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
    Yamashita T, Yoshida M, Yamada H, Asano T, Aoki A, Ikoma A, Kusaka I, Kakei M, Ishikawa SE.
    Intern Med; 2014 Sep 09; 53(8):845-9. PubMed ID: 24739604
    [Abstract] [Full Text] [Related]

  • 18. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
    Rollino C, Balbiano R, Caramello P, Roccatello D.
    G Ital Nefrol; 2013 Sep 09; 30(6):. PubMed ID: 24402662
    [Abstract] [Full Text] [Related]

  • 19. Hypokalemia with venlafaxine.
    Shang CY, Soong WT, Lin HN.
    J Clin Psychiatry; 2002 Nov 09; 63(11):1049-50. PubMed ID: 12469691
    [No Abstract] [Full Text] [Related]

  • 20. Acute Hyponatremia Resulting from Duloxetine-induced Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Yoshida K, Aburakawa Y, Suzuki Y, Kuroda K, Kimura T.
    Intern Med; 2019 Jul 01; 58(13):1939-1942. PubMed ID: 30799365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.